Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.
Strongman H, Korhonen P, Williams R, Bahmanyar S, Hoti F, Christopher S, Majak M, Kool-Houweling L, Linder M, Dolin P, Heintjes EM. Strongman H, et al. Among authors: christopher s. BMJ Open Diabetes Res Care. 2017 May 29;5(1):e000364. doi: 10.1136/bmjdrc-2016-000364. eCollection 2017. BMJ Open Diabetes Res Care. 2017. PMID: 28761650 Free PMC article.
Entacapone and prostate cancer risk in patients with Parkinson's disease.
Korhonen P, Kuoppamäki M, Prami T, Hoti F, Christopher S, Ellmén J, Aho V, Vahteristo M, Pukkala E, Haukka J. Korhonen P, et al. Among authors: christopher s. Mov Disord. 2015 Apr 15;30(5):724-8. doi: 10.1002/mds.26140. Epub 2015 Jan 16. Mov Disord. 2015. PMID: 25639262
Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study.
Strongman H, Christopher S, Majak M, Williams R, Bahmanyar S, Linder M, Heintjes EM, Bennett D, Korhonen P, Hoti F. Strongman H, et al. Among authors: christopher s. BMJ Open Diabetes Res Care. 2018 Jan 20;6(1):e000481. doi: 10.1136/bmjdrc-2017-000481. eCollection 2018. BMJ Open Diabetes Res Care. 2018. PMID: 29379607 Free PMC article.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Khunti K, Kosiborod M, Kim DJ, Kohsaka S, Lam CSP, Goh SY, Chiang CE, Shaw JE, Cavender MA, Tangri N, Franch-Nadal J, Holl RW, Jørgensen ME, Norhammar A, Eriksson JG, Zaccardi F, Karasik A, Magliano DJ, Thuresson M, Chen H, Wittbrodt E, Bodegård J, Surmont F, Fenici P; CVD-REAL Investigators and Study Group. Khunti K, et al. Cardiovasc Diabetol. 2021 Jul 31;20(1):159. doi: 10.1186/s12933-021-01345-z. Cardiovasc Diabetol. 2021. PMID: 34332558 Free PMC article.
Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study.
Goh SY, Kosiborod MN, Lam CSP, Cavender MA, Kohsaka S, Norhammar A, Birkeland KI, Holl RW, Mauricio D, Tangri N, Shaw JE, Thuresson M, Fenici P, Kim DJ; CVD-REAL Investigators and Study Group. Goh SY, et al. Diabetes Obes Metab. 2023 Aug;25(8):2402-2409. doi: 10.1111/dom.15092. Epub 2023 May 8. Diabetes Obes Metab. 2023. PMID: 37055714 No abstract available.
Evaluating the Glycemic Effects of Dolutegravir and Its Predictors Among People With Human Immunodeficiency Virus in Uganda: A Prospective Cohort Study.
Ankunda C, Agolor C, Karamagi Y, Nakubulwa S, Namasambi S, Kasamba I, Christopher SM, Kukundakwe P, Odiit M, Mubangizi I, Emunyu J, Kesi DN, Nambasa V, Ndagije HB, Mukasa B. Ankunda C, et al. Among authors: christopher sm. Open Forum Infect Dis. 2024 Oct 8;11(10):ofae596. doi: 10.1093/ofid/ofae596. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39450397 Free PMC article.
207 results